Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Ted Rogers Centre aims the application of innovation by clinicians, researchers and people with lived heart failure experience. To help mobilize knowledge and drive change, we will update this page with new tools as they become available.
An accessible reservoir of curated information on heart failure, designed to empower people with lived experience to better understand and manage their health or the health of a loved one. Visit website
Our commitment to new research and breakthrough innovations is built on an equal partnership with those who understand the disease best. Learn more
Learn about DNA, heritable traits, genetic testing and more in videos developed by SickKids, the University of Utah and the Children’s Hospital of Philadelphia. Learn more
Effective at destroying cancer cells, chemotherapy can damage healthy cells – including those in the heart. Learn more about “cardiotoxicity”, what you can do, and what type of care is best employed to keep you safe. Learn more
From Q&A panels to expressive writing workshops, we host events focused on helping people with lived experience better manage their own heart health.
Learn more
Using echocardiography to measure global longitudinal strain to see how a cancer patient’s heart muscle is changing before a decline in function occurs. Learn more
The world’s first tool that predicts the five-year risk of sudden cardiac death in young patients with hypertrophic cardiomyopathy, informing personalised care and use of ICDs. Learn more
Our unique Emergency Heart Failure Mortality Risk Grade tool helps clinicians better determine which patients can be safely discharged home and who must be admitted. Learn more
Medly is a revolutionary remote management program that makes specialized heart failure care more accessible and keeps patients safe at home. Learn more
We fund two extensive biobanks at SickKids and UHN that can underpin the novel research ideas we need to combat heart failure. Learn more
This bioinformatics tool lets you assess whole genome and whole exome sequencing data, and better identify disease-causing variants. Learn more
We seek to develop new projects and innovations built on multidisciplinary collaborations, many of which involve other research centres. Learn more